Entheon Biomedical (XCNQ:ENBI) FCF Yield % : -20.01 (As of May. 16, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Entheon Biomedical FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Entheon Biomedical's Trailing 12-Month Free Cash Flow is C$-0.27 Mil, and Market Cap is C$1.33 Mil. Therefore, Entheon Biomedical's FCF Yield % for today is -20.01%.

The historical rank and industry rank for Entheon Biomedical's FCF Yield % or its related term are showing as below:

XCNQ:ENBI' s FCF Yield % Range Over the Past 10 Years
Min: -271.37 Med: -60.92 Max: -6
Current: -20.01

During the past 7 years, the highest FCF Yield % of Entheon Biomedical was -6.00%. The lowest was -271.37%. And the median was -60.92%.

XCNQ:ENBI's FCF Yield % is ranked worse than
66.6% of 1554 companies
in the Biotechnology industry
Industry Median: -14.48 vs XCNQ:ENBI: -20.01

Entheon Biomedical's FCF Margin % for the quarter that ended in Feb. 2024 was 0.00%.

Entheon Biomedical FCF Yield % Historical Data

The historical data trend for Entheon Biomedical's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Entheon Biomedical FCF Yield % Chart

Entheon Biomedical Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Nov21

Nov22

Nov23

FCF Yield %

Get a 7-Day Free Trial

-27.93

-12.15

-17.90

-110.29

-60.92

Entheon Biomedical Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
FCF Yield %	Get a 7-Day Free Trial															-42.65	-2.32	-30.33	-31.82	-64.31

Competitive Comparison of Entheon Biomedical's FCF Yield %

For the Biotechnology subindustry, Entheon Biomedical's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Entheon Biomedical's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Entheon Biomedical's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Entheon Biomedical's FCF Yield % falls into.

Entheon Biomedical FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Entheon Biomedical's FCF Yield % for the fiscal year that ended in Nov. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-0.36	/	0.590893
	=	-60.92%

Entheon Biomedical's annualized FCF Yield % for the quarter that ended in Feb. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-0.095	*	4	/	0.590893
	=	-64.31%

Entheon Biomedical FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Entheon Biomedical FCF Yield % Related Terms

Thank you for viewing the detailed overview of Entheon Biomedical's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Entheon Biomedical (XCNQ:ENBI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Entheon Biomedical Corp (XCNQ:ENBI) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

ENTBF:USA 1XU1:Germany

Address

999 West Broadway Street, Suite 720, Vancouver, BC, CAN, V5Z 1K5

Website

https://www.entheonbiomedical.com

Entheon Biomedical Corp is a biotechnology research and development company committed to developing and commercializing a portfolio of safe and effective Dimethyltryptamine based psychedelic therapeutic products (DMT Products) for the purposes of treating addiction and substance use disorders. Entheon intends to generate revenue through the sale of its DMT Products to physicians, clinics, and licensed psychiatrists in the United States, certain countries in the European Union, and throughout Canada.

Entheon Biomedical (XCNQ:ENBI) Headlines

No Headlines